These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6390086)

  • 1. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
    Borghi VC; Wajchenberg BL; Cesar FP
    Metabolism; 1984 Dec; 33(12):1068-74. PubMed ID: 6390086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
    Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
    J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
    Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
    Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects.
    Verrillo A; de Teresa A; Martino C; di Chiara G; Verrillo L
    Regul Pept; 1988 Jun; 21(3-4):185-95. PubMed ID: 2901133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.
    Pixner T; Chaikouskaya T; Lauth W; Zimmermann G; Mörwald K; Lischka J; Furthner D; Awender E; Geiersberger S; Maruszczak K; Forslund A; Anderwald CH; Cadamuro J; Weghuber D; Bergsten P
    Front Endocrinol (Lausanne); 2024; 15():1368570. PubMed ID: 39027470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in plasma glucagon concentration in patients with diabetes mellitus and its clinical significance].
    Tang S
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):222-4, 255. PubMed ID: 1327451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
    Weiss R; D'Adamo E; Santoro N; Hershkop K; Caprio S
    J Clin Endocrinol Metab; 2011 Jan; 96(1):91-7. PubMed ID: 20843946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastro-entero-pancreatic hormone response to fasting in obesity.
    Andrews WJ; Henry RW; Alberti KG; Buchanan KD
    Diabetologia; 1981 Nov; 21(5):440-5. PubMed ID: 7028557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.